{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:41:42Z","timestamp":1790084502964,"version":"4.0.1"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020469","name":"Universidad Cient\u00edfica del Sur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020469","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Antimicrobial resistance (AMR) has emerged as a priority for both public health and the global economy. Moreover, information on AMR is scarce, particularly in low\/middle-income countries. We evaluated the direct economic cost of microorganisms and AMR.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed a cross-sectional study to assess the economic costs of neonatal cases diagnosed with bacteremia at the Instituto Nacional Materno Perinatal in Lima, Peru, from January 2017 to June 2018. We used cost invoices calculated by the micro-costing bottom-up approach, as well as the strain identification and antimicrobial susceptibility data, to estimate the direct costs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The average costs of bacteremia were US$349 (SD 403) for multidrug-resistant (MDR) strains and US$276 (SD 349) for non-MDR strains. Costs were higher for microorganisms associated with late-onset sepsis (LOS). We found that LOS, multidrug resistance and age were significantly associated with bloodstream infection (BSI) costs. Also, all microorganism groups were associated with increased costs, with the highest average costs for Acinetobacter, followed by Pseudomonas.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In Peru, BSI costs are strongly associated with AMR. Furthermore, costs increase significantly with LOS, multidrug resistance and the patient's age. We urge health authorities to strengthen measures and strategies against the pressing threat of AMR.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/inthealth\/ihaf006","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T11:24:18Z","timestamp":1737113058000},"page":"566-572","source":"Crossref","is-referenced-by-count":4,"title":["Direct economic costs related to antimicrobial resistance in bloodstream infections isolated from newborns in a perinatal hospital in Peru"],"prefix":"10.1093","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8384-2315","authenticated-orcid":false,"given":"Maria J","family":"Pons","sequence":"first","affiliation":[{"name":"Universidad Cientifica del Sur , Villa el Salvador, Lima 15067 ,","place":["Per\u00fa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio M","family":"Quispe","sequence":"additional","affiliation":[{"name":"Universidad Se\u00f1or de Sip\u00e1n , Chiclayo 1502 ,","place":["Per\u00fa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Tirado","sequence":"additional","affiliation":[{"name":"Instituto Nacional Materno Perinatal de Lima , Cercado de Lima, Lima 15001 ,","place":["Per\u00fa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Soza","sequence":"additional","affiliation":[{"name":"Instituto Nacional Materno Perinatal de Lima , Cercado de Lima, Lima 15001 ,","place":["Per\u00fa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4431-2036","authenticated-orcid":false,"given":"Joaquim","family":"Ruiz","sequence":"additional","affiliation":[{"name":"Universidad Cientifica del Sur , Villa el Salvador, Lima 15067 ,","place":["Per\u00fa"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"key":"2025070112462799200_bib1","volume-title":"Global Priority List of Antibiotic-Resistance Bacteria to Guide Research, Discovery, and Development of New Antibiotics","author":"World Health Organization","year":"2017"},{"issue":"13","key":"2025070112462799200_bib2","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.3390\/healthcare11131946","article-title":"Antimicrobial resistance: A growing serious threat for global public health","volume":"11","author":"Salam","year":"2023","journal-title":"Healthcare"},{"issue":"10325","key":"2025070112462799200_bib3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"2025070112462799200_bib4","volume-title":"Tackling Drug-Resistant Infections Globally: Final Report and Recommendations","author":"O'Neill","year":"2016"},{"key":"2025070112462799200_bib5","article-title":"The economics of antibiotic resistance","author":"McDonnell","year":"2024"},{"issue":"5","key":"2025070112462799200_bib6","doi-asserted-by":"crossref","first-page":"e0285170","DOI":"10.1371\/journal.pone.0285170","article-title":"The economic burden of antibiotic resistance: A systematic review and meta-analysis","volume":"18","author":"Poudel","year":"2023","journal-title":"PLoS One"},{"issue":"12","key":"2025070112462799200_bib7","doi-asserted-by":"crossref","first-page":"e0189621","DOI":"10.1371\/journal.pone.0189621","article-title":"Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis","volume":"12","author":"Founou","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"2025070112462799200_bib8","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3201\/eid0702.010228","article-title":"Economic impact of antimicrobial resistance","volume":"7","author":"McGowan","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"2025070112462799200_bib9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13756-020-00822-6","article-title":"A one health framework to estimate the cost of antimicrobial resistance","volume":"9","author":"Morel","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"issue":"11","key":"2025070112462799200_bib10","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3855\/jidc.12568","article-title":"Multidrug resistance bacteremia in neonates and its association with late-onset sepsis and coagulase-negative Staphylococci","volume":"14","author":"Quispe","year":"2020","journal-title":"J Infect Dev Ctries"},{"key":"2025070112462799200_bib11","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing. 28th Informational Supplement","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2018"},{"issue":"3","key":"2025070112462799200_bib12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"21","key":"2025070112462799200_bib13","doi-asserted-by":"crossref","first-page":"e38248","DOI":"10.1097\/MD.0000000000038248","article-title":"Risk factors and economic burden for community-acquired multidrug-resistant organism-associated urinary tract infections: A retrospective analysis","volume":"103","author":"Bian","year":"2024","journal-title":"Medicine"},{"issue":"4","key":"2025070112462799200_bib14","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1128\/AAC.50.4.1257-1262.2006","article-title":"Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae","volume":"50","author":"Schwaber","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2025070112462799200_bib15","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-024-02268-z","article-title":"A case-control study of the clinical and economic impact of infections caused by carbapenemase-producing enterobacterales (CPE)","volume":"52","author":"L\u00f3pez Montesinos","year":"2024","journal-title":"Infection"},{"issue":"1","key":"2025070112462799200_bib16","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1017\/ash.2023.169","article-title":"Economic burden of antimicrobial resistance and inappropriate empiric treatment in Thailand","volume":"3","author":"Kongnakorn","year":"2023","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"2025070112462799200_bib17","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.cmi.2023.12.013","article-title":"Excess resource use and cost of drug-resistant infections for six key pathogens in Europe: A systematic review and Bayesian meta-analysis","volume":"30","author":"Kingston","year":"2024","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"2025070112462799200_bib18","first-page":"126","article-title":"Coagulase-negative Staphylococci in neonatal blood: How concerning?","volume":"15","author":"Ansari","year":"2023","journal-title":"J Lab Phys"},{"issue":"07","key":"2025070112462799200_bib19","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1086\/660361","article-title":"Coagulase-negative staphylococcal infections in the neonatal intensive care unit","volume":"32","author":"Jean-Baptiste","year":"2011","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2025070112462799200_bib20","author":"WHO bacterial priority pathogens list","year":"2024","journal-title":"Bacterial Pathogens of Public Health Importance to Guide Research, Development and Strategies to Prevent and Control Antimicrobial Resistance"},{"key":"2025070112462799200_bib21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2147\/RMHP.S453686","article-title":"Extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Risk factors and economic burden among patients with bloodstream infections","volume":"17","author":"Chen","year":"2024","journal-title":"Risk Manag Healthc Policy"},{"key":"2025070112462799200_bib22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13756-018-0336-y","article-title":"Estimating the burden of antimicrobial resistance: A systematic literature review","volume":"7","author":"Naylor","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"key":"2025070112462799200_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13756-016-0114-7","article-title":"Infections caused by extended-spectrum beta-lactamases producing Enterobacteriaceae: Clinical and economic impact in patients hospitalized in 2 teaching hospitals in Dakar, Senegal","volume":"5","author":"Ndir","year":"2016","journal-title":"Antimicrob Resist Infect Control"},{"issue":"4","key":"2025070112462799200_bib24","doi-asserted-by":"crossref","first-page":"e0153076","DOI":"10.1371\/journal.pone.0153076","article-title":"Cost attributable to nosocomial bacteremia. Analysis according to microorganism and antimicrobial sensitivity in a university hospital in Barcelona","volume":"11","author":"Riu","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"2025070112462799200_bib25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jhin.2008.10.022","article-title":"Costs associated with hospital-acquired bacteraemia in an Indian hospital: A case-control study","volume":"71","author":"Kothari","year":"2009","journal-title":"J Hosp Infect"},{"issue":"2","key":"2025070112462799200_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jhin.2010.10.006","article-title":"Variations in analytical methodology for estimating costs of hospital-acquired infections: A systematic review","volume":"77","author":"Fukuda","year":"2011","journal-title":"J Hosp Infect"},{"issue":"7","key":"2025070112462799200_bib27","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3390\/antibiotics11070832","article-title":"Spread of multidrug-resistant microorganisms","volume":"11","author":"Di Lodovico","year":"2022","journal-title":"Antibiotics"},{"issue":"10014","key":"2025070112462799200_bib28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0140-6736(15)00474-2","article-title":"Access to effective antimicrobials: A worldwide challenge","volume":"387","author":"Laxminarayan","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"2025070112462799200_bib29","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jval.2010.09.008","article-title":"The time-dependent bias and its effect on extra length of stay due to nosocomial infection","volume":"14","author":"Barnett","year":"2011","journal-title":"Value Health"},{"issue":"1","key":"2025070112462799200_bib30","doi-asserted-by":"crossref","first-page":"2215149","DOI":"10.1080\/21645515.2023.2215149","article-title":"Economic and cost-effectiveness aspects of vaccines in combating antibiotic resistance","volume":"19","author":"Yemeke","year":"2023","journal-title":"Hum Vaccin Immunother"}],"container-title":["International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/inthealth\/article-pdf\/17\/4\/566\/61701551\/ihaf006.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/inthealth\/article-pdf\/17\/4\/566\/61701551\/ihaf006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T16:46:39Z","timestamp":1751388399000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/inthealth\/article\/17\/4\/566\/7990657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,1,30]]},"published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/inthealth\/ihaf006","relation":{},"ISSN":["1876-3413","1876-3405"],"issn-type":[{"value":"1876-3413","type":"print"},{"value":"1876-3405","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,1,30]]}}}